Primary Record
Nirmatrelvir
- In stock
- 3,954 g
- Purity
- 99.2 %
- CAS
- 2628280-40-8
Compound Identifiers & Properties
- CAS
- 2628280-40-8
- PubChem CID
- 155903259
- SMILES
- CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)C(F)(F)F)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)C
- Canonical SMILES
- CC(C)(C)[C@H](NC(=O)C(F)(F)F)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@H](C#N)C[C@@H]1CCNC1=O)C2(C)C
Names & Synonyms
- Nirmatrelvir
- Paxlovid
- NirmatrelvirED9
- 2628280-40-8
- Paxlovid-d9
- PF-07321332
- Nirmatrelvir [USAN]
- Boceprevir Impurity 5
- Nirmatrelvir (Standard)
- RefChem:53396
- science.abl4784, 6
- Nirmatrelvir (JAN/USAN)
- NIRMATRELVIR [INN]
- NIRMATRELVIR [JAN]
- Paxlovid (active component)
- 7R9A5P7H32
- PF07321332
- GTPL11503
- NIRMATRELVIR [WHO-DD]
- UNII-7R9A5P7H32
- CHEBI:170007
- PF07321332(nirmatrelvir)
- DTXSID501336829
- orb1298161
- CHEMBL4802135
- SCHEMBL24108848
- Pf-07321332; Nirmatrelvir
- PF07321332(nirmatrelvir)?
- C23H32F3N5O4
- MFCD34473213
- BDBM496902
- DTXCID901767123
- GLXC-23977
- PAXLOVID COMPONENT NIRMATRELVIR
- ARD168892D9
- EX-A5024
- MSK168892D9
- Paxlovid (nirmatrelvir + ritonavir)
- MSK168892
- WHO 12161
- 2628280-40-8 (Unlabelled)
- PF 07321332
- AT31194
- EBC-145089
- HY-138687R
- NCGC00846193-01
- AC-35259
- SY295161
- CID:155903259
- example E61 [WO2021250648A1]
- SID:507750842
- DB-387718
- HY-138687
- 870124 More info PF-00835231
- CS-0166635
- D12244
- (1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- SARS-CoV-2 3CLpro Inhibitor PF-07321332
- A938309
- EN300-28333908
- SARS-CoV-2-3CL Protease Inhibitor PF-07321332
- (1R,2S,5S)-N-((S)-1-Cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- C000718217
- Z4994097664
- B2693-074195
- (1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-6,6-dimethyl-3-(3-methyl-N-(trifluoroacetyl)-L-valyl)-3-azabicyclo(3.1.0)hexane-2-carboxamide
- (1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- (1R,2S,5S)-N-[(S)-1-Cyano-2-[(S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- (1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide
- 3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)-
- (1R,2S,5S)-N-((1S)-1-cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexane-2-carboxamide
- (1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-3-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- (1S,3aS,4aR)-N-[(1S)-1-cyano-2-[(3S)-2-oxotetrahydro-1H-pyrrol-3-yl]ethyl]-2-[(2S)-3,3-dimethyl-1-oxo-2-[(trifluoroacetyl)amino]butyl]-4,4-dimethyl-2,3,3a,4a-tetrahydro-1H-cyclopropa[1,2-c]pyrrole-1-carboxamide
- 3-Azabicyclo(3.1.0)hexane-2-carboxamide, N-((1S)-1-cyano-2-((3S)-2-oxo-3-pyrrolidinyl)ethyl)-3-((2S)-3,3-dimethyl-1-oxo-2-((2,2,2-trifluoroacetyl)amino)butyl)-6,6-dimethyl-, (1R,2S,5S)-
- N/A
- ZGW